Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-049674
Filing Date
2025-06-02
Accepted
2025-06-02 06:28:09
Documents
2
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0244186-6k_regencell.htm 6-K 12435
2 PRESS RELEASE, DATED JUNE 2, 2025 ea024418601ex99-1_regencell.htm EX-99.1 8210
  Complete submission text file 0001213900-25-049674.txt   21776
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Filer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-40617 | Film No.: 251013070
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)